ACQUISITIONS AND OTHER ARRANGEMENTS - Transderm Scop Narrative (Details) - Transderm Scop $ in Millions |
Mar. 31, 2021
USD ($)
|
---|---|
Asset Acquisition [Line Items] | |
Purchase price | $ 60 |
Additional cash consideration | 30 |
Contingent Consideration | 24 |
Developed Product Rights | |
Asset Acquisition [Line Items] | |
Reacquired license rights fair value total | $ 64 |
Weighted-average useful life | 9 years |
Developed Product Rights | Measurement Input Discount Rate | |
Asset Acquisition [Line Items] | |
Discount rate used to measure intangible assets | 0.225 |
Customer relationships | |
Asset Acquisition [Line Items] | |
Reacquired license rights fair value total | $ 3 |
Weighted-average useful life | 7 years |
Customer relationships | Measurement Input Discount Rate | |
Asset Acquisition [Line Items] | |
Discount rate used to measure intangible assets | 0.155 |
X | ||||||||||
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of input used to measure alternative investment. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|